The present invention relates to tartrate salts of quinazoline containing zinc-binding moiety based derivatives that are inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The tartrate salts may further act as HDAC inhibitors.

 
Web www.patentalert.com

< Cyclopropyl Amide Derivatives 978

> VEGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY

> METHODS AND COMPOSITIONS FOR TREATING PAIN

~ 00506